3M™ Transpore™ 1534-0Recalls & reported problems

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 30707387525911), received between Aug 13, 2021 and Nov 16, 2022 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

• InjuryNov 16, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  RECEIVED FROM CHINA: A PATIENT WHO WAS ADMITTED TO THE NEUROLOGY DEPARTMENT FOR TREATMENT DUE TO NERVOUS CONVULSIONS RECEIVED AN INJECTION OF MEDICATION AND THE NEEDLE WAS THEN REMOVED NEEDLE AND SKIN DAMAGE WITH CONTINUED BLEEDING WAS ALLEGED WHERE 3M TRANSPORE WHITE SURGICAL TAPE WAS APPLIED. WOUND HEMOSTASIS WAS PERFORMED, AND A DRESSING WAS USED ON THE WOUND, WHICH WAS CHANGED DAILY, AND HOSPITALIZATION WAS PROLONGED.

  Patient problems: Local Reaction; Localized Skin Lesion

  MAUDE report 15810546 ↗
• InjuryAug 13, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  RECEIVED FROM(B)(6) : A PATIENT DEVELOPED A LARGE RASH ON THE CHEEK WITH USE OF 3M TRANSPORE WHITE SURGICAL TAPE WAS USED TO AFFIX A TRACHEAL TUBE AFTER A LAPAROSCOPIC TOTAL HYSTERECTOMY, PERFORMED UNDER GENERAL ANESTHESIA, FOR UTERINE FIBROIDS. THE RASH IMPROVED WITHIN FIFTEEN MINUTES AFTER 40 MG OF METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION WAS ADMINISTERED INTRAVENOUSLY.

  Patient problems: Local Reaction; Rash

  MAUDE report 12320838 ↗